SQUAWK/NEWS
Account
Theme
Account
Menu
Live News NEWS FLASH L impact

Dyne Therapeutics Is Maintained at Buy by HC Wainwright & Co.

Ratings actions from Benzinga: GMT) Dyne Therapeutics Price Target Cut to $32.00/Share From $50.00 by HC Wainwright & Co.Ratings actions from Benzinga

DYN

Related stories